Viewing StudyNCT06047080

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:32 PM
Last Modification Date: 2024-10-26 @ 3:08 PM
Study NCT ID: NCT06047080
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2023-09-14
Brief Title: An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin Rituximab Cyclophosphamide Doxorubicin and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Large B-Cell Lymphoma
Keywords: